Bringing the fundamentals into focus…
Back to Kyntra Bio, Inc.
How Kyntra Bio, Inc. stacks up
KYNB · against 21 other Healthcare companies of similar size
Valuation
33/ 100
Above the middle of the pack.
Ranked #4 of 22 · scores higher than 67% of peers
Bars: peers in each 10-point band of the valuation score7 peers with a valuation score of 30–39, including KYNB · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -218.1% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -177.3% vs peer median 1.5%
- Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.
Metric by metric
Position: dot = KYNB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KYNB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 21 reported | -177.3% | -118.3% | 45% | 30% | |
| EBITDA yieldHigher is better · 25 reported | 184.6% | -13.3% | 88% | 50% | |
| Free cash flow yieldHigher is better · 14 reported | -218.1% | -118.6% | 15% | 20% | |
| Book yieldHigher is better · 24 reported | -172.7% | 107.5% | 4% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around KYNB| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 272M HKD (≈$35M) | 97 | 59 | |
| 2 | 14.3B KRW (≈$10M) | 71 | 53 | |
| 3 | 3.5B JPY (≈$24M) | 65 | 48 | |
| 4 | 30M USD | 33 | ||
| 4 | 23M USD | 33 | ||
| 4 | 34M USD | 33 | 19 | |
| 4 | 22M USD | 33 | 47 | |
| 4 | 17M USD | 33 | 10 | |
| 9 | 21.3B KRW (≈$15M) | 30 | 28 | |
| 9 | 12M USD | 30 | 38 | |
| 11 | 17M USD | 8 | 16 | |
| 11 | 250M SEK (≈$25M) | 8 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score